Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.440
-0.030 (-1.21%)
At close: Mar 13, 2026, 4:00 PM EDT
2.519
+0.079 (3.22%)
After-hours: Mar 13, 2026, 7:59 PM EDT

Esperion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
627907431353465304
Market Cap Growth
91.57%110.57%21.91%-23.92%52.62%-56.45%
Enterprise Value
1,007989.58580.98535.82558.28303.87
Last Close Price
2.443.702.202.996.235.00
PE Ratio
--33.64-7.86-1.47-1.77-0.54
Forward PE
15.7412.2616.60---
PS Ratio
1.552.251.303.046.163.88
PB Ratio
--3.00-1.11-0.78-1.43-1.55
P/TBV Ratio
-1.68-2.55-1.06-0.68-1.28-0.73
P/FCF Ratio
--69.30-17.97-2.61-2.66-1.15
P/OCF Ratio
--69.30-18.22-2.61-2.66-1.15
EV/Sales Ratio
2.502.451.754.617.403.87
EV/EBITDA Ratio
16.6716.3910.67-3.45-3.12-1.34
EV/EBIT Ratio
16.7016.4210.68-3.44-3.11-1.34
EV/FCF Ratio
--75.58-24.24-3.95-3.19-1.15
Debt / Equity Ratio
-0.83-0.83-0.76-0.58-0.80-1.31
Debt / EBITDA Ratio
4.184.185.46-1.71-1.46-1.15
Debt / FCF Ratio
-19.26-19.26-12.41-1.96-1.49-0.99
Net Debt / Equity Ratio
-0.28-0.28-0.39-0.40-0.290.00
Net Debt / EBITDA Ratio
1.401.402.81-1.18-0.530.00
Net Debt / FCF Ratio
-6.44-6.44-6.38-1.36-0.540.00
Asset Turnover
1.001.001.210.510.240.21
Inventory Turnover
1.291.290.860.860.770.56
Quick Ratio
1.021.020.910.842.173.85
Current Ratio
1.541.541.371.292.674.48
Return on Equity (ROE)
6.57%6.57%12.27%53.74%89.74%183.64%
Return on Assets (ROA)
16.20%16.20%19.80%-68.57%-57.03%-61.71%
Return on Invested Capital (ROIC)
69.92%69.92%114.11%-668.69%-423.87%-1456.06%
Return on Capital Employed (ROCE)
45.89%45.89%73.94%-151.62%-77.39%-79.92%
Earnings Yield
-3.62%-2.97%-12.73%-67.89%-56.50%-186.20%
FCF Yield
-2.09%-1.44%-5.56%-38.33%-37.63%-86.67%
Buyback Yield / Dilution
-10.84%-10.84%-24.60%-18.66%-19.56%-73.08%
Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q